Get more information on ways you can experience fast RDS success

Interested in learning more about CUROSURF, and how it fits your NICU protocols? Please use this form to contact us for more information about CUROSURF or the CUROSURF Experience Program. To reach us by phone, call (888) 466-6505 and you will be connected with the Cornerstone Customer Service department.

You can also use this form to request customer service support or for additional medical information. To contact the Cornerstone Medical Information department directly, please call (888) 661-9260, fax (866) 443-3092, or send an email to medical@crtx.com.

Please fill out your contact information in the space provided.

Required Fields*

Name*

Practice or hospital*

Address 1*

Address 2

City*

State*

ZIP*

Email*

Re-enter email*

Phone

Tell us which types of information you would like to receive (check all that apply).^†

I would like more information about CUROSURF

I would like to speak to CUROSURF Customer Service about a new or existing order

I would like to speak to a CUROSURF Neonatal Sales Specialist

I would like more information about evaluating CUROSURF and the CUROSURF Experience Program

I would like to receive additional medical information related to CUROSURF and RDS

^†By checking these boxes, you are giving Cornerstone Therapeutics permission to send or contact you with the information you have requested, as well as information and updates on CUROSURF or other Cornerstone products in the future. Cornerstone Therapeutics will not sell or share any of your information with third parties.

Use the space below to provide us with any details about your request:

Indication

CUROSURF^® (poractant alfa) Intratracheal Suspension is indicated for the treatment (rescue) of respiratory distress syndrome (RDS) in premature infants. CUROSURF reduces mortality and pneumothoraces associated with RDS.

Important Safety Information

CUROSURF is intended for intratracheal use only. THE ADMINISTRATION OF EXOGENOUS SURFACTANTS, INCLUDING CUROSURF, CAN RAPIDLY AFFECT OXYGENATION AND LUNG COMPLIANCE. Therefore, infants receiving CUROSURF should receive frequent clinical and laboratory assessments so that oxygen and ventilatory support can be modified in response to respiratory changes.

CUROSURF should only be administered by those trained and experienced in the care, resuscitation, and stabilization of preterm infants.

TRANSIENT ADVERSE EFFECTS SEEN WITH THE ADMINISTRATION OF CUROSURF INCLUDE BRADYCARDIA, HYPOTENSION, ENDOTRACHEAL TUBE BLOCKAGE, AND OXYGEN DESATURATION. These events require stopping CUROSURF administration and taking appropriate measures to alleviate the condition. After the patient is stable, dosing may proceed with appropriate monitoring.

Click here for full prescribing information

This site is intended for United States residents only.